Expressing the sense of the House of Representatives that biotechnology firms meeting small business standards are critical to the United States, its people and its economy because they create new medicines, services, and jobs and meet unmet needs related to populations and patients with infectious and chronic diseases, including those of medically underserved populations.

referredUnited States· United States Congress· EN

Introduced

12 March 2010

Last action

12 March 2010 · Introduced

Status

Referred to the House Committee on Energy and Commerce.

Summary

Recognizes: (1) that the public deserves the safest, most effective, and efficient processes to save the lives of people living in the United States with infectious and chronic diseases; and (2) the need to coordinate existing public funding to help small business biotechnology firms whose products may be lost due to domestic economic conditions, and to fund critical paths for small biotechnology drug development and for regulatory review and commercial approval. Expresses support for: (1) the domestic development and commercialization of biotechnology research by firms meeting small business size standards and collaborations with university-based biotechnology research facilities; and (2) the advancement of U.S.-based commercialization of point of care therapeutics and diagnostics by emerging and small business biotechnology firms for domestic and global use. Encourages: (1) the development of a national strategic framework to facilitate technological advancements in improving the commercialization processes for small business biotechnology firms; (2) the creation of incentives for small business biotechnology companies that perform basic and applied research through the development and commercialization of biotechnology products and processes and their diffusion into national and local economies; (3) the development of a comprehensive approach to describing disease populations and the production of comprehensive research programs that are current with evolving biotechnology and the unmet needs of diverse patient populations; and (4) the Office of the Secretary of Health and Human Services (HHS) to develop a Federal Biotechnology Coordinating Council representative of small business biotechnology companies, research facilities, and federal agencies with a strategic initiative to facilitate development and preserve these small business biotechnology firms and coordinate resources and funding mechanisms.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

12 March 2010
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
12 March 2010
Introduced
Introduced in House
Source: IntroReferral
12 March 2010
Introduced
Introduced in House
Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Introduced in House · 12 March 2010 · Download file

Documents

3 official files

Introduced in House (text)

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Introduced in House (text)
Introduced in House · EN · 12 March 2010
View Download Open at official source
Introduced in House (PDF)
Introduced in House · EN · 12 March 2010
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 12 March 2010
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/111th-congress/house-resolution/1179
Open data entity: https://api.congress.gov/v3/bill/111/hres/1179
us · 111-hres-1179 · source updated 2 January 2025